In mammary carcinoma, the importance of this pathway was demonstrated by the application of a low molecular weight inhibitor of IKK2, which not only prevented EMT induction by CA-IKK2, but also attenuated metastasis from orthotopic sites induced by 4T1 cells [69]. Here, IKBKB is linked to breast carcinoma.